S. Laguerre

发表

Capecitabine plus oxaliplatin (XELOX) versus 5-fluorouracil/folinic acid plus oxaliplatin (FOLFOX-4) as second-line therapy in metastatic colorectal cancer: a randomized phase III noninferiority study.

Y. Bang, L. Siu, D. Cunningham, 2008, Annals of oncology : official journal of the European Society for Medical Oncology.